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Abstract
A common limitation of neuroimaging studies is their small sample sizes. To overcome this 
hurdle, the Enhancing Neuro Imaging Genetics through Meta-Analysis (ENIGMA) Consortium 
combines neuroimaging data from many institutions worldwide. However, this introduces 
heterogeneity due to different scanning devices and sequences. ENIGMA projects commonly 
address this heterogeneity with random-effects meta-analysis or mixed-effects mega-analysis. 
Here we tested whether the batch adjustment method, ComBat, can further reduce site-related 
heterogeneity and thus increase statistical power. We conducted random-effects meta-analyses, 
mixed-effects mega-analyses and ComBat mega-analyses to compare cortical thickness, surface 
area and subcortical volumes between 2897 individuals with a diagnosis of schizophrenia and 
3141 healthy controls from 33 sites. Specifically, we compared the imaging data between 
individuals with schizophrenia and healthy controls, covarying for age and sex. The use of 
ComBat substantially increased the statistical significance of the findings as compared to random-
effects meta-analyses. The findings were more similar when comparing ComBat with mixed-
effects mega-analysis, although ComBat still slightly increased the statistical significance. ComBat 
also showed increased statistical power when we repeated the analyses with fewer sites. Results 
were nearly identical when we applied the ComBat harmonization separately for cortical 
thickness, cortical surface area and subcortical volumes. Therefore, we recommend applying the 
ComBat function to attenuate potential effects of site in ENIGMA projects and other multi-site 
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structural imaging work. We provide easy-to-use functions in R that work even if imaging data are 
partially missing in some brain regions, and they can be trained with one data set and then applied 
to another (a requirement for some analyses such as machine learning).
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1. Introduction
After the early reporting of ventricular enlargement in patients with schizophrenia (SCZ) 
using pneumoencephalography (Huber, 1957), there has been an exponential increase in the 
number of studies that use imaging techniques to detect brain differences in people with 
psychiatric disorders. This increase is most evident for studies using magnetic resonance 
imaging (MRI), probably due to its high resolution and its wide availability around the 
globe. However, most MRI studies have examined relatively small sample sizes, a limitation 
that may prevent the detection of true differences (type II errors), and because of the use of 
liberal thresholds, may even lead to increased detection of false differences (type I errors). 
Consequently, reports of unreliable, inconsistent and even contradictory results are not 
uncommon (Radua and Mataix-Cols, 2012).
Collaborative multi-site initiatives provide an opportunity to assemble larger and more 
diverse groups of subjects, leading to increased power and findings that may be more 
representative of the general population. Among these initiatives, the ENIGMA (Enhancing 
Neuro Imaging Genetics through Meta-Analysis; http://enigma.ini.usc.edu) Consortium 
(Thompson et al., 2014) stands out for including hundreds of groups worldwide and 
facilitating the sharing of tens of thousands of neuroimages. One great advantage of this 
consortium is the harmonization of the protocols to pre-process the MRI data, which has 
decreased the heterogeneity between the sites related to methodological factors. All sites 
apply the same pre-processing pipelines to obtain thickness and surface area estimates for 
cortical regions of interest (ROI) and volume estimates for subcortical ROIs; similar 
harmonized protocols are in use for standardized analysis of diffusion MRI, resting state 
fMRI and EEG data, as well as various kinds of omics data (GWAS and epigenetic data).
However, even though all sites participating in an ENIGMA project apply the same pre-
processing protocol, data from different sites still show relevant methodological 
heterogeneity due to systematic differences in MRI scanning devices and acquisition 
sequences. Also, prior studies have reported that the results of the FreeSurfer segmentation 
process, for morphometric analysis of MRI, can be affected even by using different 
FreeSurfer versions, workstations or operating systems (Chepkoech et al., 2016; 
Gronenschild et al., 2012). Most ENIGMA projects address this residual heterogeneity by 
random-effects meta-analysis (RE-Meta), but estimation and control of heterogeneity in site-
aggregated meta-analyses may be suboptimal (Chen and Benedetti, 2017). It is worth noting 
that a few ENIGMA studies have analyzed shared individual data (rather than site-
aggregated statistical data). These “mega-analyses” of individual data considered the “site” 
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as a random factor within a linear mixed-effects model (ME-Mega), and in several cases 
examined so far, showed higher statistical power than RE-Meta (Boedhoe et al., 2017, 2018; 
Favre et al., 2019; van Rooij et al., 2018) (Table 1).
Here, we tested whether ME-Mega may be further improved using a recently developed 
method to control for batch effects. Standard ME-Mega assumes that the error terms follow 
the same normal distribution at all sites, which is rarely the case as sites usually have 
different error variances. In addition, both RE-Mega and ME-Meta estimate the 
heterogeneity of each ROI independently, while it is likely that all ROIs share some 
heterogeneity. One method that overcomes these issues is ComBat (Johnson et al., 2007), a 
batch adjustment method developed for genomics data. Fortin and colleagues have shown 
that ComBat mega-analysis (ComBat-Mega) outperformed other methods for removing the 
effects of site from cortical thickness data obtained using the ANTs cortical thickness 
pipeline (Tustison et al., 2014) from a moderately small number of different sites (≤7 sites). 
Specifically, ComBat decreased scan-related heterogeneity and increased statistical power 
and reproducibility (Fortin et al., 2018). The current study examines whether this 
harmonization result can be extended to ENIGMA data obtained using a standardized 
FreeSurfer pipeline (Dale et al., 1999; Fischl et al., 1999). Moreover, we did not know 
whether the use of a larger number of sites could minimize the advantages of ComBat-Mega 
as compared to ME-Mega. To answer these questions, we analyzed the main structural MRI 
data from the ENIGMA Schizophrenia Working Group using RE-Meta, ME-Mega and 
ComBat-Mega, and then compared the findings. The RE-Meta of these data have been 
already published (van Erp et al., 2016, 2018; Wong et al., 2019); in those analyses, 
individuals with SCZ showed widespread thinner cortex and smaller surface area, as well as 
smaller hippocampus, amygdala, thalamus and accumbens volumes, and larger pallidum and 
lateral ventricle volumes.
We hypothesized that ComBat-Mega would show improvements over RE-Meta and ME-
Mega in detecting differences between groups of individuals with SCZ and healthy controls 
(CON), with standard errors of these effects scaling by method: Combat-Mega < ME-Mega 
< RE-Meta. We further provide the R code (http://enigma.ini.usc.edu/wp-content/uploads/
combat_for_ENIGMA_sMRI/combat_for_ENIGMA_sMRI.R) for the application of 
ComBat harmonization for other ENIGMA mega-analyses or other multi-site structural 
imaging work even if the imaging data are partially missing in some ROIs (the original 
ComBat function did not accept missing data).
2. Methods
2.1. Methodological approaches
Before detailing the collection of data and analyses in the present study, we will briefly 
explain the three methodological approaches. To exemplify the explanation, we will refer to 
a simple comparison of cortical thickness between groups of individuals with SCZ and 
CON, after covarying for effects of age and sex, but the concepts are applicable to other 
measures and statistical contrasts. We also conducted an alternative analysis covarying for 
age, sex, and intracranial volume (ICV).
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2.1.1. The RE-Meta approach—In the random-effects meta-analysis (RE-Meta), a 
linear model estimates the difference in cortical thickness between SCZ and CON for each 
ROI at each site, covarying for age and sex:
yr, i, j = αr, i + Xi, j ⋅ βr, i + εr, i, j
where yr,i,j is the measurement of cortical thickness of the rth ROI from the jth individual of 
the ith site, αr,i is the estimate overall cortical thickness of the rth ROI from individuals of 
the ith site, Xi,j are the values of the variables (disorder, age, and sex) of the jth individual of 
the ith site, βr,i are the estimates of the coefficients of these variables for the rth ROI from 
individuals of the ith site, and εr,i,j is the error term for the rth ROI in the jth individual of the 
ith site.
Estimates of coefficients of interest (e.g., βr,i,1, the difference between SCZ and CON are 
then pooled to obtain a single estimate for each ROI (βr,meta,1). A typical method to pool the 
coefficients is the weighted mean of the coefficient of each site (Radua and Mataix-Cols, 
2012):
βr, meta, 1 = ∑
i ∈ sites
wr, i ⋅ βr, i, 1
where wr,i the weight of ith site for the rth ROI, and is calculated as the inverse of the 
variance of βr,i,1, plus the heterogeneity for the rth ROI (τr2):
wr, i =
1
var βr, i, 1 + τr2
Frequently, the analyst does not use the coefficients but effect sizes, such as Hedges’ g 
(Radua and Mataix-Cols, 2012), but the concept is similar.
Some problems of RE-Meta are that βr,i may be poorly estimated in sites with small sample 
sizes, or that τr2 may be poorly estimated in some scenarios (Chen and Benedetti, 2017).
2.1.2. The ME-Mega approach—In the standard mixed effects mega-analysis (ME-
Mega), a linear mixed-effects model is performed on shared individual subject data to 
estimate the overall difference in cortical thickness between SCZ and CON, for each ROI, 
covarying for age and sex. This analysis is conducted in a single step, with “site” included in 
the model as a random factor:
yr, i, j = αr + Xi, j ⋅ βr + γr, i + εr, i, j
where αr is the estimate overall cortical thickness of the rth ROI from all individuals, βr are 
the estimates of the coefficients of the variables for the rth ROI from all individuals, and γr,i 
are the additive effects of the ith site in the rth ROI.
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This approach benefits from a more robust estimation of αr and βr as it is based on the data 
from all sites, as well as from a more precise estimation of the heterogeneity. However, it 
still may have some minor issues. It assumes that the error terms follow the same normal 
distribution at all sites, which may seldom be the case. We acknowledge that it is possible to 
create linear mixed-effects models that consider a different variance for each site, but they 
involve the specification of variance structures for each statistical test, which may 
substantially complicate the analyses. In addition, the effects of site are estimated 
independently for each ROI, which may be suboptimal because the effects of site, even if 
different for each ROI, may still share some commonalities (e.g., an MRI device may yield a 
better signal contrast than another across the brain).
2.1.3. The ComBat-mega approach—As compared to ME-Mega, the Combat mega-
analysis (ComBat-Mega) assumes that the error terms may follow varying normal 
distributions at different sites:
yr, i, j = αr + Xi, j ⋅ βr + γr, i + δr . i + εr, i, j
where δr,i are the multiplicative effects of the ith site in the rth ROI.
In addition, it assumes that the additive and multiplicative effects of the sites are not 
completely independent across ROIs but, rather, they share a common distribution. Such 
considerations prevent the use of standard linear models, but ComBat uses an empirical 
Bayes framework to estimate the distribution of the effects of site (Johnson et al., 2007). 
Once estimated, it derives the additive error terms:
εr, i, j =
yr, i, j − αr − Xi, j ⋅ βr − γr, i
δr . i
These terms allow the derivation of harmonized data:
yr, i, jComBat = αr + Xi, j ⋅ βr + εr, i, j
These simpler data can then be analyzed with standard linear models to estimate the overall 
difference in cortical thickness between SCZ and CON groups, for each ROI.
2.2. Modifications of the ComBat function
Fortin and colleagues modified the original “combat” function, in the “sva” package for R 
(Leek et al., 2019), so that it could be applied to imaging data (Fortin et al., 2017). However, 
Fortin’s “combat” function may not be easily applicable to ENIGMA projects as it requires 
that the dataset has no missing data, which is seldom the case. In addition, it finds the 
harmonization parameters and applies them to the data within the same function, while some 
analyses - such as machine learning - require that the parameters are found in a training set 
and later applied to an independent test set (this is not the case here, but it might be the case 
in future studies). We further modified the “combat” function to allow for missing data and 
to separate the fitting and the application of the harmonization.
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First, we divided the function into two subfunctions: “combat_fit”, which finds the 
harmonization parameters, and “combat_apply”, which applies them to the same or to 
another set. The “combat_fit” function automatically imputes missing data so that the 
function can find the harmonization parameters without errors. These imputations are 
predictions based on linear models of the ROI values by the covariates, separately for each 
ROI and each site:
yr, i, j = αr, i + Xi, j ⋅ βr, i
The covariates are the variables introduced into the “combat_fit” function, which in the 
present study were the diagnosis, age, and sex. The “combat_fit” function also discards ROIs 
with no variance, which returned errors in the previous “combat” function. Importantly, 
these imputations are temporary and only aimed to avoid errors during the fitting of the 
parameters, they are not saved. To apply the parameters, the user must use the 
“combat_apply” function with the original data, and missing values are not imputed.
The reader may download the adapted ComBat functions for R from http://
enigma.ini.usc.edu/wp-content/uploads/combat_for_ENIGMA_sMRI/
combat_for_ENIGMA_sMRI.R.
2.3. Collection of data
The data for this paper includes the cortical thickness, surface area and subcortical volumes 
from 33 sites of the ENIGMA Schizophrenia Working Group (van Erp et al., 2016, 2018; 
Wong et al., 2019) who shared individual subject level FreeSurfer data for this project. The 
overall sample included 2897 individuals with a diagnosis of SCZ (mean age 34 years, 34% 
females) and 3141 CON (mean age 33 years, 49% females). For SCZ, the mean age of onset 
was 23 years and their Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987) 
scores for total/positive/negative symptoms were 61/16/17, respectively. The researchers at 
each of the sites had collected the data after obtaining participants’ written informed 
consent, with protocols that had been approved by local institutional review boards. We 
provide a description of the overall sample in Table 2 and a description of the sample from 
each site in Supplementary Table S1.
All sites had processed the data with FreeSurfer (Fischl, 2012) versions 4.0 to 5.3, except for 
version 5.2 which was found to produce low intra-class correlations compared to the other 
versions, and within site all patients and controls were processed using the same FreeSurfer 
version (van Erp et al., 2016, 2018) according to the ENIGMA protocols, which are 
available at http://enigma.usc.edu/protocols/imaging-protocols. For cortical ROIs, they 
involved the estimation of cortical vertex-wise statistics, the extraction of cortical thickness 
and surface area for 70 Desikan-Killiany (DK) atlas regions (Desikan et al., 2006), and 
quality checks (van Erp et al., 2018). For subcortical ROIs, they involved the estimation of 
subcortical volumes and quality checks (van Erp et al., 2016).
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2.4. Statistical analyses
We conducted comparisons of MRI data between individuals with SCZ and CON to assess 
the statistical significance, power and familywise error rate (FWER) using RE-Meta, ME-
Mega and ComBat-Mega. We formally tested whether ComBat-Mega increases the 
statistical significance and power of the differences between individuals with SCZ and CON 
by attenuating site-effects, using a permutation test and a small-subset strategy respectively. 
We also used the data of the permutation test to check the FWER.
2.4.1. Comparisons of MRI data between individuals with SCZ and CON—We 
conducted the RE-Meta in two steps. In the first step, we compared the values of each ROI 
between SCZ and CON via a standard linear model, with age and sex as covariates, 
separately for each site. We then converted the difference to a Hedges’ g and its variance for 
each site and ROI. In the second step, we conducted a random-effects meta-analysis of the 
Hedges’ g of each ROI with the “metafor” package for R (Viechtbauer, 2010), and we 
corrected the p-values for multiple comparisons with the Holm method.
For ME-Mega, we compared the values of each ROI between SCZ and CON via a linear 
mixed-effects model, with age and sex as covariates and site as a random factor, with the 
“lme4” and “lmerTest” packages for R (Bates et al., 2015; Kuznetsova et al., 2017). We then 
divided the difference by the standard deviation (derived from the model) and corrected it 
for small-sample bias to obtain a Hedges’ g and its variance, and we corrected the p-values 
for multiple comparisons using the Holm method (Holm, 1979).
Finally, for ComBat-Mega, we first removed the effects of site using the ComBat functions 
(modelling the effects of diagnosis, age, and sex), and then compared the values of each ROI 
(e.g., cortical thickness of the frontal pole) between SCZ and CON via a standard linear 
model, with age and sex as covariates. Note that the ComBat functions use covariates (e.g., 
age and sex) to better estimate the effects of site, but they do not remove the effects of these 
covariates; for this reason, we included these covariates in the subsequent linear model. As 
for ME-Mega, we converted the difference to a Hedges’ g and its variance, and we corrected 
the p-values for multiple comparisons with the Holm method. Note that we applied a single 
ComBat harmonization for different types of data (cortical thickness, cortical surface area, 
and subcortical volume) because we considered that they were related. We also conducted an 
alternative analysis with a separate harmonization for each type of data.
2.4.2. Comparison of the statistical significance—To test whether ComBat-Mega 
had improved the statistical significance we used a permutation approach. We followed the 
Draper-Stoneman procedure, which according to results from a study comparing different 
algorithms (Winkler et al., 2014), is one of the procedures that best controls the FWER and 
that can be safely applied here. Note that other algorithms such as Freedman Lane would 
produce different permuted data for RE-Meta, ME-Mega and ComBat-Mega, which would 
be problematic in our study because these unwanted differences could confound other 
potential differences between the methods. Specifically, we randomly permuted the 
diagnosis among the individuals within each site and repeated all comparison analysis 1000 
times.
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To show the differences in statistical significance between methods expected by chance, we 
plotted the histogram of the median difference in the logit-transformed p-values between the 
methods across the permutations (Fig. 1). For example, in one permutation we randomly 
assigned study participants to patient or control status. We then compared these randomly 
assigned patients and controls using RE-Meta, ME-Mega and ComBat-Mega. We then 
calculated differences between logit-transformed p-values of the ComBat-Mega comparison 
and logit-transformed p-values of the RE-Meta (or ME-Mega) comparisons for each ROI. 
From these, we only saved the median between logit-transformed p-value difference. Note 
that this median difference should be very close to zero, given that participant assignment 
was random, and there should therefore be no patient-control group differences other than by 
chance. By conducting multiple of these permutations, we were able plot the histogram of 
the median differences expected by chance alone. Finally, we compared the median 
difference of the original analysis (with correctly assigned patient and control status) with 
the histogram of the median differences expected by chance. Only median differences were 
used in this analysis to simplify the test as doing so avoids the need to correct for multiple 
comparisons.
We must note that without the logit (or other) transforms, the detection of differences in 
statistical significance would be too sensitive for large p-values and too little sensitive for 
small p-values. For example, if the (non-transformed) p-value using one approach was 0.6 
and the (non-transformed) p-value using another approach was 0.4, the difference in p-
values would be very large (0.6–0.4 = 0.2) even if the two p-values might be considered 
conceptually very similar, whereas if the (non-transformed) p-value using one approach was 
0.003 and the (non-transformed) p-value using another approach was 0.001, the difference in 
p-values would be very small (0.003–0.001 = 0.002) even if one p-value is three times the 
size of the other. With the logit transform, the p-values of the first example would be 0.4 and 
−0.4, with a difference of 0.8, and the p-values of the second example would be −5.8 and 
−6.9, with a difference of 1.1.
The use of a permutation test implied that both the estimated probability of obtaining the 
observed median difference in (logit-transform) p-values was discrete, i.e., it could only be 
0.001, or 0.002, or 0.003, etcetera. However, we were only interested in assessing if this 
estimation was <0.05, for what this level of precision should not pose any problems.
2.4.3. Evaluation of the statistical power—We also tested whether ComBat-Mega 
increases the statistical power using a small-subset strategy. Specifically, we repeated 500 
times the analyses but including each time only a random sample of 10 sites. We then 
counted the number of times that these analyses using only 10 sites were able to detect 
differences between SCZ and CON. We only used ROIs in which the differences between 
SCZ and CON were strongly statistically significant in the main analyses using the 33 sites 
(FWER<0.001 for RE-Meta, for ME-Mega, and for ComBat-Mega), as we assumed that 
they have true differences. Finally, we conducted a Wilcoxon signed-ranked test to compare 
the statistical power across ROIs between ComBat-Mega and RE-Meta, as well as between 
ComBat-Mega and ME-Mega.
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2.4.4. Determination of the empirical FWER—We also used the permutation data 
created above to check whether the FWER for the three methods were appropriate, i.e., we 
counted the proportion of permutations in which at least one ROI had a Holm-corrected p-
value < 0.05. Again, the use of a permutation test implied that the estimated FWER was 
discrete, but we were only interested in assessing whether it was <0.05.
3. Results
With ComBat-Mega, on average, individuals with a diagnosis of SCZ showed thinner cortex 
and smaller surface area in nearly all cortical ROIs (Table 3). The only exceptions were the 
bilateral pericalcarine fissures and right entorhinal cortex (where between-group differences 
in thickness did not reach statistical significance after correction for multiple comparisons) 
and the left isthmus of the cingulate and right temporal pole (where between-group 
differences in surface area did not reach statistical significance after correction for multiple 
comparisons). The SCZ group also showed, on average, smaller bilateral thalamus, 
hippocampus, amygdala, and right accumbens volumes, and larger bilateral lateral ventricle, 
putamen, and pallidum volumes. Smaller left accumbens and larger bilateral caudate 
volumes were not statistically significant after correction for multiple comparisons.
Results were in the same direction for the RE-Meta and ME-Mega, though RE-Meta did not 
detect thinner cortex in three ROIs (bilateral rostral anterior cingulate and left caudal 
anterior cingulate) and smaller surface area in six ROIs (bilateral pericalcarine fissure, left 
posterior cingulate and temporal pole, and right isthmus cingulate and insula).
The Hedges’ g estimates for the differences were similar across the different analytic 
methods, but their statistical significance was greater in ComBat-Mega as compared to RE-
Meta and ME-Mega (Figs. 2 and 3). The difference in statistical significance was relatively 
minor when comparing ComBat-Mega to ME-Mega, whereas particularly relevant when 
comparing ComBat-Mega to RE-Meta (Fig. 3).
The median difference between logit-transformed ComBat-Mega p-values and logit-
transformed RE-Meta p-values in the original data was 13.9. This was substantially larger 
than any of the median differences in the permuted data (all < 0.61), indicating that the 
higher statistical significance of ComBat-Mega findings was unlikely due to chance 
(probability 0.001) (Fig. 4). For the comparison between ComBat-Mega and ME-Mega, the 
median difference was smaller (3.2), but still unlikely due to chance (all median differences 
in the permuted data <0.52, probability 0.001).
Interestingly, a plot of the ComBat-Mega-related increase in statistical significance as a 
function of the intra-site variance/total variance ratio, showed that the increase in statistical 
significance was larger in those ROIs in which intra-site variance was only ~50–70% of total 
variance compared to those ROIs in which intra-site variance was ~90–100% of total 
variance (p < 0.001, Fig. 5).
In the evaluation of statistical power using the small-subset strategy, the statistical power 
was higher for ComBat-Mega (statistical power = 83.5%) than for RE-Meta (statistical 
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power = 53.7%; Wilcoxon p-value < 0.001) or ME-Mega (statistical power = 80.4%; 
Wilcoxon p-value < 0.001).
The empirical FWER was ≤0.05 for all analytic methods (RE-Meta: 0.024; ME-Mega: 
0.027; ComBat-Mega: 0.025).
When we applied the ComBat harmonization separately for cortical thickness data, cortical 
surface area data and subcortical volume data, we found the same differences with nearly 
identical Hedges’ g (Supplementary Figure S1). The statistical significance was minimally 
lower (median difference between single ComBat logit-transformed p-values and separate 
ComBat logit-transformed p-values was 0.1), the statistical power in the small-subset 
strategy was 83.5%, and the empirical FWER was 0.026.
When we covaried ComBat-Mega by age, sex and ICV, results were similar: The only 
differences were that the right frontal pole, isthmus of the cingulate and pericalcarine and 
left parahippocampal and temporal pole decreases in surface area were no longer statistically 
significant, whereas the left pericalcarine decrease in surface area and the bilateral caudate 
increases in volume reached statistical significance. Results were again in the same direction 
for the RE-Meta and ME-Mega, though RE-Meta did not detect statistically significant 
differences in 36 of the ROIs showing differences with ComBat-Mega, and ME-Mega did 
not detect smaller right accumbens volume (and detected smaller surface area in left 
parahippocampal and right pericalcarine but not in left paracentral and right entorhinal). The 
Hedges’ g estimates for the differences were again similar across the different analytic 
methods, but their statistical significance was again greater in ComBat-Mega as compared to 
RE-Meta and ME-Mega (Supplementary Figure S2).
4. Discussion
In this study, we analyzed individual subject level data pooled by the ENIGMA 
Schizophrenia Working Group using three methods to account for the effects of site: 
random-effects meta-analysis (RE-Meta), linear mixed-effects models (ME-Mega), and 
ComBat harmonization followed by standard linear models (ComBat-Mega). The results of 
the comparison between SCZ and CON using ComBat-Mega were similar to the studies 
already published by the ENIGMA Schizophrenia Working Group: SCZ showed a 
widespread thinner cortex and smaller surface area (van Erp et al., 2018), smaller 
hippocampus, amygdala, thalamus and accumbens, and larger lateral ventricles, putamen 
and pallidum (van Erp et al., 2016) than CON. The results of the same comparison using 
RE-Meta and ME-Mega were in the same direction and had similar effect sizes, although 
with a lower statistical significance (i.e. wider confidence intervals, larger p-values), 
especially for RE-Meta. In other words, the use of ComBat increased the statistical 
significance (i.e., narrower confidence intervals, smaller p-values) of the differences between 
SCZ and CON. This was specially apparent in those ROIs in which intra-site variance was 
only ~50–70% of total variance. ComBat Mega also showed increased statistical power 
when we repeated the analyses with fewer sites. All approaches controlled well the FWER, 
even too strictly probably due to the use of the Holm method, which is more powerful than 
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the Bonferroni method but still conservative (Blakesley et al., 2009). Findings were similar 
when covarying by ICV.
Based on these findings, we recommend that ENIGMA mega-analysis projects consider 
applying the ComBat function to reduce the effects of site, followed by standard statistical 
analysis without including site as a fixed or random effect in the statistical model. To apply 
ComBat harmonization, we provide easy-to-use functions for R that work even if there are 
missing data and they can be trained with data from one set and then applied to data from 
another.
We must note that we conducted these analyses with the three main types of data used in 
ENIGMA projects: thickness of cortical ROIs, surface area of cortical ROIs, and volumes of 
subcortical nuclei. However, some ENIGMA projects use other types of data, such as mean 
fractional anisotropy of white matter tracts, and we have not explored whether the 
application of ComBat would be beneficial for these projects. Two notions suggest that 
ComBat should be broadly beneficial. On the one hand, the ComBat algorithm is not 
specific for a given type of imaging data. Indeed, while it was developed for genomics data 
(Johnson et al., 2007), we here successfully applied it to three types of ENIGMA imaging 
data. Moreover, Fortin and colleagues found that ComBat outperforms other harmonization 
methods for voxel-based fractional anisotropy and mean diffusivity (Fortin et al., 2017), and 
Yu et al. found similar results for resting-state functional connectivity and network measures 
(Yu et al., 2018).
While our findings suggest that ComBat harmonization will be useful for most ENIGMA 
mega-analyses and other multi-site structural imaging work, we suggest caution when 
combining different types of data. We conducted a single ComBat harmonization for 
different types of MRI data because we considered that thickness, area, and volume are 
related, as they are obtained from the same FreeSurfer output of the T1-weighted image and 
all measure amounts of gray matter. Indeed, an alternative analysis with separate ComBat 
harmonization for each type of data yielded nearly identical results. However, we do not 
know whether the application of a single ComBat harmonization on other combinations of 
data would behave similarly.
Other popular approaches for pooling neuroimaging data are the voxel-based meta-analytic 
methods, such as Seed-based d Mapping (SDM) (Albajes-Eizagirre et al., 2019; Radua et al., 
2012) or Activation Likelihood Estimation (ALE) (Eickhoff et al., 2009, 2012). These 
methods can include imaging studies even if they only report the coordinates of the peaks of 
the clusters of statistical significance. Therefore, a great advantage of these methods is the 
exhaustive inclusion of studies. In addition, the analyses are conducted at the voxel level 
(rather than using ROIs). These methods traditionally tested whether the reported findings 
tended to converge in a few brain voxels (Albaje-s-Eizagirre and Radua, 2018), but novel 
methods are able to directly test whether there are differences - even if they are widespread 
and do not converge (Albaje- s-Eizagirre et al., 2019). In view of the results of the present 
study, one could wonder whether these voxel-based methods should also conduct ComBat 
mega-analysis instead of meta-analysis. However, to use ComBat they would need access to 
individual subject level data, which at present are often not available. Another aspect to 
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consider is whether we need SDM or ALE meta-analyses after an ENIGMA ComBat mega-
analysis is published. Here, we must remember that SDM and ALE are voxel-based and 
include virtually all published studies, whereas most ENIGMA studies are ROI-based and 
include only the data that authors agree to share. Therefore, these different approaches 
present interesting complementary information.
Our study has some limitations. First, we already stated that we have not explored whether 
the application of ComBat would be beneficial for projects using other types of data, 
although several facts suggest that ComBat should be broadly beneficial. Second, we also 
acknowledged that we do not know whether the application of a single ComBat 
harmonization on other combinations of data would behave similarly. Third, our analysis is 
focused on the differences between SCZ and CON, whose distribution is roughly similar 
across sites. The effects of site and thus the importance of their removal might be larger for 
conditions with few cases in each site, where pooling data is more beneficial. Fourth, 
ComBat-Mega addresses some issues but not others, which still need to be investigated, such 
as site by nuisance confounds. For example, a site with poor quality data may also be a site 
with a mean age higher than other sites. Future studies addressing these questions could 
point to methods other than ComBat. Finally, there is a conceptual difference in the effects 
of site that are modeled in ComBat/ME-Mega and the effects of site that are modeled in RE-
Meta. The former effects are in (individual) raw data and refer to site-specific constants that 
are added to or that multiply the measurements. The latter effects, conversely, are in (group) 
effect sizes, and are probably a mix of several factors such as site-specific constants that 
multiply the measurements, heterogeneity in the differences between SCZ and CON, or 
differences in precision between studies.
To conclude, this paper provides evidence of the superiority of ComBat harmonization over 
standard mega-analyses and meta-analyses in reducing site-related heterogeneity and thus 
increase statistical power. We therefore recommend that ENIGMA mega-analysis projects 
and other multi-site structural imaging work consider applying the ComBat function, which 
we provide employing easy functions for R. The provided code works with missing data and 
allows for harmonization of a test set based on the training set (a requirement for machine 
learning and possibly replication studies). We hope that future ENIGMA mega-analysis 
projects will improve between-site harmonization using ComBat.
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Fig. 1. 
Steps of each iteration of the permutation test used to compare the statistical significance 
between random-effects meta-analysis, mixed-effects mega-analysis and ComBat mega-
analysis
Footnote: ComBat-Mega: ComBat mega-analysis; ME-Mega: mixed-effects mega-analysis; 
RE-Meta: random-effects meta-analysis.
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Fig. 2. 
Forest plot for random-effect meta-analysis (light red), mixed-effects mega-analysis (blue) 
and ComBat mega-analysis (dark green).
Footnote: The width of the confidence intervals in the legend corresponds to the mean width 
of the confidence intervals across the brain. ComBat-Mega: ComBat mega-analysis; ME-
Mega: mixed-effects mega-analysis; RE-Meta: random-effects meta-analysis.
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Fig. 3. 
Hedges’ g and p-values of random-effect meta-analysis, mixed-effects mega-analysis and 
ComBat mega-analysis in the comparison of ENIGMA brain data between 2897 patients 
with schizophrenia and 3141 healthy controls.
Footnote: Each cross represents an ROI. ComBat-Mega: ComBat mega-analysis; ME-Mega: 
mixed-effects mega-analysis; RE-Meta: random-effects meta-analysis. The top plots show 
that ComBat-Mega effect sizes are similar to RE-Meta and ME-Mega effect sizes, as crosses 
are mostly distributed around the diagonal lines. The bottom plots show that ComBat-Mega 
p-values are substantially smaller than RE-Meta p-values (crosses are clearly above the 
diagonal line), and slightly smaller than ME-Mega p-values (crosses tend to be slightly 
above the diagonal line).
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Fig. 4. 
Median difference between logit-transformed p-values derived from ComBat mega-analysis 
and logit-transformed p-values derived from random-effects meta-analysis and mixed-effects 
mega-analysis in the original data (red) and in the permuted data (histograms).
Footnote: ComBat-Mega: ComBat mega-analysis; ME-Mega: mixed-effects mega-analysis; 
RE-Meta: random-effects meta-analysis. The histograms (in gray) show the expected 
ComBat-Mega-related increase of statistical significance by chance, and the arrows (in red) 
show the actual increase. The latter is clearly larger than that former (negative values mean 
that ComBat-Mega increases statistical significance).
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Fig. 5. 
Relationship between the intra-site variance/total variance ratio and ComBat mega-analysis-
related increase of statistical significance.
Footnote: ComBat-Mega: ComBat mega-analysis; ME-Mega: mixed-effects mega-analysis; 
RE-Meta: random-effects meta-analysis. The ComBat-Mega-related increase of statistical 
significance (negative values in the Y axis) is larger in regions with lower intra-site variance/
variance ratio (around 50–70%).
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Table 1
Previous ENIGMA projects that included both mega-analyses and meta-analyses.
RE-Meta ME-Mega
Subcortical volumes in obsessive-compulsive disorder (Boedhoe et al., 2017) ↓ in1 ROI and t in ↑ ROI ↓ in 1 ROI and ↑ in 1 ROI
Fractional anisotropy in bipolar disorder (Favre et al., 2019) ↓ in 23 out of 44 ROIs ↓ in 29 out of 44 ROIs
Cortical thickness in obsessive-compulsive disorder (Boedhoe et al., 2018) No findings ↓ in 2 ROIs
Surface area in obsessive-compulsive disorder (Boedhoe et al., 2018) ↓ in 1 ROI ↓ in 1 ROI
Subcortical volumes in autism spectrum disorder (van Rooij et al., 2018) ↓ in 3 ROIs ↓ in 4 ROIs
Cortical thickness in autism spectrum disorder (van Rooij et al., 2018) ↑ in 3 ROIs ↓I in 10 ROIs ↑ in 9 ROIs and ↓ in 7 ROIs
Footnote: ROI: region of interest. ME-Mega: mixed-effects mega-analysis; RE-Meta: random-effects meta-analysis.
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